Pneumococcal conjugate vaccine (Prevnar; Wyeth) with pneumococcal polysaccharide vaccine (23-valent) and tetanus/diphtheria vaccine.

Trial Profile

Pneumococcal conjugate vaccine (Prevnar; Wyeth) with pneumococcal polysaccharide vaccine (23-valent) and tetanus/diphtheria vaccine.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Mar 2012

At a glance

  • Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Diphtheria-tetanus vaccine; Pneumococcal vaccine
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 13 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top